Pennybreakout
Significant Junior Gold Exploration Discovery (80-150% upside)Significant results were encountered in hole DKL-20-RC-007, which returned 4.83 grams-per-tonne (“g/t”) gold (“Au”) over 20 meters, including 14.51 g/t Au over 6m (also including 39.6 g/t over 2m).
Nexus Gold is primed for a breakout and they are currently waiting on the remaining 6 holes from their recently drilling program in West Africa that today in hole #7 found a significant discovery for the company.
The company has several drilling programs lined up for 2021 at a few highly anticipated drill sites.
2022 PT $1.25
Hive Blockchain Very Promising along with BTC breakout.Do your own research.
I am just sharing my own opinion, My analysis are not an investment advice.
AITX ready for next run upWhole market was bleeding the first day of the new year and AITX closed the day 17% down. I believe this was mostly because of all overdue profit realizations since people waited for new tax year to cash out some of their profits.
If you have been trading AITX you know that 17% is not really a loss for this stock. We hit the bottom of our rising channel and managed to keep the price around 0.03 level.
Considering the increasing interest on AITX and the news that's expected this month, along with no fear of R/S or dilution we will test the first resistance at 0.043-0.045 level and then head up towards 0.072 and eventually 0.1
Almaden Minerals $AAU - Penny Stock Idea 💡 🚀This idea is based on my technical analysis only.
Do your research and trade on your own risk!
Starts PMs Production Next Year in a $1700+ and $19+ EnvironmentI prefer to look at and use logarithmic charts because they're less dramatic but included the regular one for comparison.
DYDD.
The targets I put on the chart are conservative. Conceivably a $3 to $5+ stock. In the medium and long-run I think it makes new all-time highs.
Technical Analysis doesn't have to be fancy.
AITX leaving Oversold area for a higher rangeSince the dilution ended this robotics company is ready to see the sunny meadows.
After a 700% increase in 1 week it took a little breather and dropped down to oversold area.
With new sales agreements in the pipeline investor anticipation is starting to load up in this area.
In the short run 0.0054-0.0059 is the resistance area that will hold it down until the news come out.
If it touches this area it will come back to the new support at 0.0036 and continue consolidating above this for the next run up.
It's highly possible to make serious $$$ during this zigzag.
In the long run AITX will be breaking above $0.01 most likely in the first months of 2021.
RLFTF - Penny Stock Heating UpAnticipating some positive news from RLFTF's and further FDA approval for it's Aviptadil.
ABCDE Triagle wave approaching completion, confirmed by Williams Alligator, and Fib Retracement
A bounced off 0.382 level
C bounced off 0.5 level
Look for E confirmation off 0.618 level
Should price exit the triangle formation, setting target @ $1.2
💥 Compression Play, Acer Therapeutics. (ACER)✌ You will want to play the breakout to the up or downside on the green triangle I have drawn.We are testing the top of a longterm downward Resistance.
Daily Timeframe
Crossover Strategy: Doji
The EMA Dots: 3/3 Red
Support Level: Bottom Green Triangle
Resistance Level: Top Green Triangle
Play the breakout and line up the indicators.
Have an awesome day! ✌
🥇MLT | MAJOR LEAGUE TRADER
Gulf Marine Services - penny Rocket 🚀 or penny Plummet 📉At glance you might think GMS price chart suggest their in big trouble but is there light at the end of the tunnel?
Last year GMS revenue fell by 12% and their actual loss for the year totalled $85.5 million, 2019 was evidently a difficult year for them however chairman Tim Summers stated that "agreement has been reached with lenders on the key terms of restructuring our bank debt which will give GMS renewed access to liquidity and a firm financial platform to move the business forward through 2020 and beyond”
Last month GMS was awarded a six month renewable energy contract to provided support as an unnamed UK offshore renewable operator. And with Summers stating that " the company's financial performance to the end of March 2020 is slightly better than its 2020 business plan." buyers can start to have a bit more confidence.
At the end of last month Seafox applied for a takeover deal of GMS but was rejected with GMS claiming 'it has strengthened its board and secured new business' however I wouldn't write-off a future takeover.
Past price action has also shown a definite correlation between the companies stock price and the value of a barrel of oil. With that being said oil prices are currently on the up 📈 and as a result I expect CMS's share price to do the same.
Scenario 1 : The price could fall back to support after recently gaining 745% (29/04 - 04/06) and then bounce upwards from around the 6.85 level.
Scenario 2 : The price could just continue to rise in the same expectation that oil prices will
Scenario 3 : Buyer confidence could be reduced with worrying loss figures coupled with takeover doubts and the price could just continue the long term trend of further depreciation.
This is purely an idea please ensure you conduct your own analysis and ensure risk management is in place before conducting any market execution.
New ASX SmallCap with 30%+ Profit PotentialHunting for a LONG on ATOMO ASX:AT1
I've been watching AT1 for a while since it came on the market and it didn't look attractive because it was so new and volatile.
However, I've since noticed that it's attempting to cross the downtrend line and also break up through resistance.
I must stress - important to wait to clear these levels before engaging. Yes, you pay more, but its a safer trade.
I'm not waiting for AT1 to clear and close above $0.36 before entering for a long.
TRADE SPECIFICS:
ENTRY - $0.37
TAKE PROFIT 1 - $0.475 - 30% PROFIT
TAKE PROFIT 2 - $0.52 - 42% PROFIT
STOP LOSS - $0.31
RISK : REWARD - 1 : 2
This is the 1HR chart I'm looking at, so assumptions are based here, however this is OK for me as I have reviewed the 4HR already and came to the same conclusions. Safe players might apply the same engagement above but wait for a close above $0.36 on the 4HR rather.
If you like my ideas, please LIKE and FOLLOW me! :-)
Reminder - this is not financial advice, simply an idea. Please do your own research before entering any trades and ensure you use risk management such as stop losses.
Remember, there is only 5 outcomes when you enter a trade:
1. Break Even
2. Small Win
3. Small Loss
4. Big Win
5. Big Loss
Eliminate #5 from your future options.
Happy Hunting!
Did IGXT Just Give It All Back?IGXT traded almost the same share volume as previous on Monday with a big red candle. Does this signal weakness for the stock and will it be able to hold levels at or above the previous gap it had from months prior?
"The biotech penny stock 's price increased by 61.5% over the month. It started with the company presenting at the H.C Wainwright 21st Annual Global Investment Conference which occurred on September 9th. Towards the end of the month, IntelGenx announced its resubmission of RIZAPORT’s New Drug Application."*
Volume is always something to pay attention to especially when you talk about finding penny stocks to watch .
*Quote Source: 5 Money Making Penny Stocks To Watch This Week
Stock: IGXT
Is The News Enough for KGKG?KGKG came back from the dead today but is that news going to be enough to keep the trend going next week?
"The company announced distribution through 15 new distributors in 14 states. The deal will see Kona Gold’s hemp energy drinks and CBD waters go on sale in new markets. The company is now partnered with 31 distributors and has distribution in 30 states. Chris Selinger, V.P. of Sales of Kona Gold Solutions, Inc. said, “With the opening of our South Carolina distribution center, we will have the capability and capacity to service our growing distributor network.”
From 5 Penny Stocks To Buy Or Sell Next Week? - on PennyStocks.com
SELLAS Announces Pricing of $15 Million Public Offering.SELLAS intends to use the net proceeds from the offering to commence a pivotal Phase 3 trial for its lead clinical candidate, galinpepimut-S (“GPS”), as a monotherapy in acute myeloid leukemia patients following second complete remission and to continue its Phase 1/2 basket type trial of GPS in combination with pembrolizumab, as well as for general corporate purposes and funding its working capital needs.
BIGG Breakout comingShorts getting squeezed out, double bottom + higher low price action, accelerating volume, consecutive upper wicking on the day chart, news catalysts in the pipeline, BTC short term bullishness = $$$$$$$
STRAP IN.
Calling 0.15-0.175 by midweek (or sooner)
JP<3
RETC looks like a longI am currently expecting the price to explode to the upside. With a potential of 46% reward...
A very clean setup.
VDRM FULL DD PACKAGEALL THE DD ON VDRM YOU NEED RIGHT HERE (repost)
2dollarbill Saturday, 08/19/17 10:19:12 AM
Re: None
Post #
26410
of 26411 Go
ALL THE DD ON VDRM YOU NEED RIGHT HERE
FDA approved products that ViaDerma (VDRM) offers:
-skin cancer therapies (Cantrile)
-stem cell therapy product (TetraStem Plus)
-topical antibiotics (TetraStem the world’s strongest broad-spectrum topical antibiotic available)
-TETRA-STEM – a tetracycline hydrochloride ointment. An award-winning antibiotic/wound healing product that kills all knows bacteria, including "flesh-eating" bacteria. Tertra-stem also can be used to treat wounds, ulcers
-topical anti-viral product (Viralcur) for genital herpes anti-fungal products for onychomycocis (OnyPro)
-hair loss prevention product (HairGain)
-ACNECLIR/ACNEEN – a salicylic acid based lotion that treats acne
-ECODERM – a colloidal oatmeal lotion for Eczema
-ACNECYCLINE – a tetracycline hydrochloride ointment that treats acne
-DERMONEEN – a salicylic acid lotion used to treat Psoriasis
-IVYMED – a zinc acetate based liquid that treats Poison Ivy rashes
- STAPHWASH PLUS – a zinc acetate based liquid. This is a non-antibiotic skin cleanser that kills MRSA
-TETRA-ABC – a tetracycline hydrochloride based ointment. This is an oil based topical antibiotic that kills all known bacterial infections. A water based version of this product is also available.
-STINGMED – a zinc acetate based liquid that treats most insect and spider bites
-ADVANCED JELLYFISH STING KIT – a zinc acetate powder, for suspension, that treats Jellyfish stings
-VENOMX – a zinc acetate based liquid used topically to treat snake bites.
-Product for treatment of Migraines presently; with a future of possibly ( inflammation of fibromyalgia, Cohn’s disease, nicotine addiction, schizophrenia, and pain management for Multiple Sclerosis and cancer. utilizing (CBD's) Calanoids and (THC) Tetrahydrocannabinol
biotechs trade at 30x earnings or 5x gross sales or 15x net sales or on air if they are a r and d company, with VDRM we have sales coming this year here is the analysis broken down below
ie...from the 500,000 bottles alone will yield $62.5M gross sales
$62.5m in gross sales X 5x gross sales = 325m market cap = $1.00 - $1.50 target
OR
62.5m in gross sales @ a 50% margin = $31m in net sales X 15x net sales = 450m market cap = $2.00 + target
OR
62.5m in gross sales with a $31m in net sales which divided by outstanding stock = 0.15 cents earnings X 30x earnings (pe - price to earnings) = $4.50 + target
Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results. Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity. Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.
Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $3.02 billion/year
Psoriasis- $7.3 billion/year
Eczema- $2.5 billion/year
Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transformoral medication into topical products. Ability to enable active ingredients with a rapid transport direct to the site of action.
Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life. Facilitates transfer of chemicals through the stratum corneum with
Hornbeck ready for a launchHornbeck is looking ready for a big move. Just wondering where it will be.
Fingers crossed for this one.
PYR lots more room to moveThe upside has to 1.35, lots of room to move after the next break upwards.
The next break will be large as it is hitting previous supply.
Watch this thing move. Buy on the upsloping line. Target 1.35 or higher.
